Subsequent Events - Additional Information (Detail) - USD ($) |
1 Months Ended | |
|---|---|---|
Oct. 31, 2015 |
Sep. 30, 2015 |
|
| Subsequent Event [Line Items] | ||
| Working Capital | $ 500,000 | |
| Subsequent Event [Member] | ||
| Subsequent Event [Line Items] | ||
| Debt Issuance Cost | $ 12,600,000 | |
| Allocated Share-based Compensation Expense | 1,300,000 | |
| Subsequent Event [Member] | Cb Pharma Acquisition Corp [Member] | ||
| Subsequent Event [Line Items] | ||
| Working Capital | $ 50,000 |
| X | ||||||||||
- Definition Represents the value of difference between current assets and current liabilities. No definition available.
|
| X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of debt issuance costs (for example, but not limited to, legal, accounting, broker, and regulatory fees). No definition available.
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|